SCHEMBL9894833

SCHEMBL9894833

CS(=O)(=O)c1cccc(C(Cc2ccc(F)cc2)C(=O)Nc2nc3ccccc3o2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 8/20 0.43
CSNK1D P48730 1/20 0.41
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
VNN1 O95497 1/20 0.39
CTSS P25774 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.38
PTPN2 P17706 5/20 0.37
GALK1 P51570 1/20 0.37
FFAR2 O15552 1/20 0.37
SCD O00767 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.36
TSHR P16473 1/20 0.36
HSPD1 P10809 1/20 0.36
PTPN5 P54829 1/20 0.36
HSPE1 P61604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9895818 0.90 PTPN1 (0.45) PTPN1CSNK1DMAPTKMT2ANPC1
SCHEMBL9895023 0.90 PTPN1 (0.45) PTPN1CSNK1DMAPTKMT2ANPC1
SCHEMBL9894659 0.86 PTPN1 (0.42) PTPN1CSNK1DMAPTKMT2ANPC1
SCHEMBL9896229 0.84 CSNK1D (0.50) PTPN1CSNK1DMAPTKMT2ANPC1
SCHEMBL9896000 0.83 AKT1 (0.43) PTPN1MAPTKMT2ACTSSFFAR2
SCHEMBL9894828 0.82 FFAR2 (0.45) MAPTKMT2ATP53SMN1; SMN2CTSS
SCHEMBL9895215 0.82 NPC1 (0.44) PTPN1CSNK1DKMT2ANPC1TP53
SCHEMBL9897188 0.81 PTPN2 (0.46) PTPN1CSNK1DMAPTKMT2ANPC1
SCHEMBL9895191 0.81 GCK (0.40) PTPN1CTSSGALK1FFAR2
SCHEMBL9894922 0.81 XDH (0.41) PTPN1MAPTTP53FFAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 US claimed
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 US disclosed
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149718-A1 Amido Compounds P2RX7, P2RX3, P2RX2 PTPN1 852/4885CSNK1D 2063/4885MAPT 3543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.